Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study

INTRODUCTION: Prophylactic administration of hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogues (NAs) is the standard treatment for controlling hepatitis B virus (HBV) recurrence after liver transplantation (LT). Since lifelong use of HBIG is expensive and inconvenient and the antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Anli, Guo, Zhiyong, Ren, Qingqi, Wu, Linwei, Ma, Yi, Hu, Anbin, Wang, Dongping, Ye, Haidan, Zhu, Xiaofeng, Ju, Weiqiang, He, Xiaoshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690662/
https://www.ncbi.nlm.nih.gov/pubmed/29145470
http://dx.doi.org/10.1371/journal.pone.0188190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690662/
https://www.ncbi.nlm.nih.gov/pubmed/29145470
http://dx.doi.org/10.1371/journal.pone.0188190

Ejemplares similares